Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes

被引:144
作者
Brugarolas, J
Kaelin, WG
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA
关键词
D O I
10.1016/j.ccr.2004.06.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The LKB1 tumor suppressor protein controls the activity of the TSC1/TSC2 tumor suppressor complex. Mutations in LKB1 cause Peutz-Jeghers syndrome (PJS), and mutations in either TSC1 or TSC2 cause tuberous sclerosis complex-two syndromes characterized by the development of hamartomas. LKB1 activation by energy deprivation activates AMPK, which in turn phosphorylates and activates TSC2. TSC2 activation results in the inactivation of mTOR, a critical regulator of protein translation. How mTOR dysregulation after inactivation of LKB1 or TSC1/2 contributes to hamartoma development is not known. However, hypoxia-inducible factor (HIF) and VEGF are regulated by mTOR and are likely to play a contributory role.
引用
收藏
页码:7 / 10
页数:4
相关论文
共 47 条
  • [1] Gene encoding protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer
    Anand, N
    Murthy, S
    Amann, G
    Wernick, M
    Porter, LA
    Cukier, IH
    Collins, C
    Gray, JW
    Diebold, J
    Demetrick, DJ
    Lee, JM
    [J]. NATURE GENETICS, 2002, 31 (03) : 301 - 305
  • [2] Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells
    Avdulov, S
    Li, S
    Michalek, V
    Burrichter, D
    Peterson, M
    Perlman, DM
    Manivel, JC
    Sonenberg, N
    Yee, D
    Bitterman, PB
    Polunovsky, VA
    [J]. CANCER CELL, 2004, 5 (06) : 553 - 563
  • [3] Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation
    Bardeesy, N
    Sinha, M
    Hezel, AF
    Signoretti, S
    Hathaway, NA
    Sharpless, NE
    Loda, M
    Carrasco, DR
    DePinho, RA
    [J]. NATURE, 2002, 419 (6903) : 162 - 167
  • [4] LKB1, a protein kinase regulating cell proliferation and polarity
    Boudeau, J
    Sapkota, G
    Alessi, DR
    [J]. FEBS LETTERS, 2003, 546 (01) : 159 - 165
  • [5] TSC2 regulates VEGF through mTOR-dependent and -independent pathways
    Brugarolas, JB
    Vazquez, F
    Reddy, A
    Sellers, WR
    Kaelin, WG
    [J]. CANCER CELL, 2003, 4 (02) : 147 - 158
  • [6] The phosphoinositide 3-kinase pathway
    Cantley, LC
    [J]. SCIENCE, 2002, 296 (5573) : 1655 - 1657
  • [7] The AMP-activated protein kinase cascade - a unifying system for energy control
    Carling, D
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2004, 29 (01) : 18 - 24
  • [8] Molecular genetic advances in tuberous sclerosis
    Cheadle, JP
    Reeve, MP
    Sampson, JR
    Kwiatkowski, DJ
    [J]. HUMAN GENETICS, 2000, 107 (02) : 97 - 114
  • [9] CORRANDEI MN, 2004, IN PRESS GENES DEV
  • [10] Oncogenic alterations of metabolism
    Dang, CV
    Semenza, GL
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1999, 24 (02) : 68 - 72